BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17151676)

  • 1. Breast cancer research neglects non-Jewish groups, experts charge.
    Keim B
    Nat Med; 2006 Dec; 12(12):1335. PubMed ID: 17151676
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Are you Jewish?'.
    New Sci; 2005 Jul 9-15; 187(2507):7. PubMed ID: 16178105
    [No Abstract]   [Full Text] [Related]  

  • 3. Is there a cure for cancer ads?
    Kahn J
    Fortune; 2003 Mar; 147(4):46. PubMed ID: 12633023
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene patent fight.
    New Sci; 2005 Jun 25-Jul 1; 186(2505):7. PubMed ID: 16178103
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Corporations flock to selling for the (breast cancer) cure.
    Braun S
    J Natl Cancer Inst; 2005 Feb; 97(4):320. PubMed ID: 15713970
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethical issues related to BRCA gene testing in orthodox Jewish women.
    Mor P; Oberle K
    Nurs Ethics; 2008 Jul; 15(4):512-22. PubMed ID: 18515440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitute decisions about genetic testing in critical care research: a glimpse behind the curtain.
    Lavery JV; Slutsky AS
    Crit Care Med; 2006 Apr; 34(4):1257-9. PubMed ID: 16550080
    [No Abstract]   [Full Text] [Related]  

  • 8. Corporations flock to selling for the (breast cancer) cure.
    Twombly R
    J Natl Cancer Inst; 2004 Dec; 96(23):1736-7. PubMed ID: 15572752
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer gene sequencing: ethical challenges and promises.
    Devarakonda S; Govindan R; Hammerman PS
    Virtual Mentor; 2012 Nov; 14(11):868-72. PubMed ID: 23351899
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioethics, the genome, and the Jewish body.
    Wolpe PR
    Conserv Jud; 2002; 54(3):14-25. PubMed ID: 12735298
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast cancer screening for Korean women must consider traditional risks as well as two genetic risk factors: genetic polymorphisms and inheritable gene mutations.
    Anderson G; Jun M; Choi K
    Cancer Nurs; 2007; 30(3):213-22. PubMed ID: 17510585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory breast cancer: patient advocate view.
    Mason G; Johnson O
    Semin Oncol; 2008 Feb; 35(1):87-91. PubMed ID: 18308150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of trends in incidence and mortality rates of breast cancer, incidence to mortality ratio and stage at diagnosis between Arab and Jewish women in Israel, 1979-2002.
    Tarabeia J; Baron-Epel O; Barchana M; Liphshitz I; Ifrah A; Fishler Y; Green MS
    Eur J Cancer Prev; 2007 Feb; 16(1):36-42. PubMed ID: 17220702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical research. No lifeline for proposed breast cancer prevention trial.
    Kaiser J
    Science; 2007 Jun; 316(5832):1679. PubMed ID: 17588904
    [No Abstract]   [Full Text] [Related]  

  • 15. National Cancer Act: a look back and forward.
    Vanchieri C
    J Natl Cancer Inst; 2007 Mar; 99(5):342-5. PubMed ID: 17341721
    [No Abstract]   [Full Text] [Related]  

  • 16. Perceptions of genetic testing for cancer predisposition among Ashkenazi Jewish women.
    Lewis MJ; Peterson SK
    Community Genet; 2007; 10(2):72-81. PubMed ID: 17380056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To boost breast cancer research, a center banks on healthy tissue.
    Scudellari M
    Nat Med; 2010 Jan; 16(1):4. PubMed ID: 20057391
    [No Abstract]   [Full Text] [Related]  

  • 18. Europe to pay royalties for cancer gene.
    Abbott A
    Nature; 2008 Dec; 456(7222):556. PubMed ID: 19052591
    [No Abstract]   [Full Text] [Related]  

  • 19. Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.
    Kelly KM; Senter L; Leventhal H; Ozakinci G; Porter K
    Patient Educ Couns; 2008 Jan; 70(1):135-42. PubMed ID: 17988821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predisposition to breast cancer: Europe closes its doors to Myriad Genetics (Salt Lake City)].
    Nau JY
    Rev Med Suisse; 2007 Oct; 3(128):2320. PubMed ID: 17985613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.